Moderate to Severe Plaque PsoriasisLOTOSNCT01077232
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
An observational study of Moderate to Severe Plaque Psoriasis, run by AbbVie (prior sponsor, Abbott) at 641 sites in Germany.
Trial summary
Safety and Effectiveness of adalimumab (Humira) in Psoriasis Patients in Routine Clinical Practice. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Moderate to Severe Plaque Psoriasis
- How many people
- 5,442 participants
- Where
- 641 sitesGermany
- Study dates
- 4 Jan 2008to 30 Jun 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Community Sample: Patients with Plaque Psoriasis
Who may be able to join
- Moderate to severe plaque psoriasis in adults with no response to other systemic therapy (e.g. cyclosporine, methotrexate or PUVA (photochemical therapy)) or patients with a contraindication or hypersensitivity to such a therapy
Who cannot join
- Hypersensitivity against the drug or one of the other ingredients; active tuberculosis or other severe infections (e.g. sepsis and opportunistic infections); moderate to severe cardiac insufficiency
Trial locations and contacts
641 sites in 1 country.
300 sites in 1 country
Germany300 sites
Praxis M. Vilic /ID# 210108
Aachen, North Rhine-Westphalia, 52062
Universitaetsklinikum Aachen /ID# 35037
Aachen, North Rhine-Westphalia, 52074
Hoeller-Obrigkeit, Aachen, DE /ID# 60599
Aachen, 52064
Petri, Ahaus, DE /ID# 53712
Ahaus, 48683
Gewiss, Ahrensburg, DE /ID# 33431
Ahrensburg, 22926
Praxis Dr. Schuessler /ID# 149404
Alsfeld, 36304
Oster-Schmidt, Altenkirchen, D /ID# 126022
Altenkirchen, 57610
Weiss, Amberg, DE /ID# 60613
Amberg, 92224
Dietz, Ampfing, DE /ID# 50790
Ampfing, 84539
Bell, Andernach, DE /ID# 99815
Andernach, 56626
Schulz, Angermuende, DE /ID# 53719
Angermünde, 16278
Rebbien, Annaberg-Buchholz, DE /ID# 35052
Annaberg-Buchholz, 9456
Thieme, Artern, DE /ID# 35518
Artern, 06556
Dr. Szlava Fuezesi, Achaffenbu /ID# 118537
Aschaffenburg, 63739
Theuring, Aschersleben, DE /ID# 35058
Aschersleben, 06449
Hums, Aue, DE /ID# 60601
Aue, 08280
Gerloff-Steiner, Aue, DE /ID# 53694
Aue, 8280
Schneider & Sedlmayr, Augsburg /ID# 33351
Augsburg, 86167
Lechner/Stuebich, Aurich, DE /ID# 33355
Aurich, 26603
Lechner/Stuebich, Aurich, DE /ID# 67967
Aurich, 26603
Brautzsch, Bad Berka, DE /ID# 33365
Bad Berka, 99438
Broschewitz/Hammer Bad Doberan /ID# 60596
Bad Doberan, 19209
Broschewitz/Hammer Bad Doberan /ID# 67948
Bad Doberan, 19209
Mauer, Bad Kreuznach, DE /ID# 126019
Bad Kreuznach, 55543
Schulz, Bad Muender, DE /ID# 48469
Bad Münder am Deister, 31848
SALUS-Klinik /ID# 33405
Bad Reichenhall, 83435
Praxis Dr. Bock /ID# 166127
Bad Rothenfelde, 49214
Houda, Bad Schlema, DE /ID# 35584
Bad Schlema, 8301
Moerstedt, Bad Woerishofen, DE /ID# 99844
Bad Wörishofen, 86825
Sozialstiftung Bamberg /ID# 33430
Bamberg, 96049
Stephan-Dahm, Bargteheide, DE /ID# 50861
Bargteheide, 22941
Dr. Roxana Homolka, Baunatal, /ID# 118539
Baunatal, 34225
Mirtschink, Bautzen, DE /ID# 50851
Bautzen, 02625
Graessel, Bayreuth, DE /ID# 35587
Bayreuth, 95444
Kinateder, Bayreuth, DE /ID# 33439
Bayreuth, 95444
Blaese & Walther, Bendorf, DE /ID# 50787
Bendorf, 56170
Pflieger-Bruss, Benndorf, DE /ID# 53713
Benndorf, 56170
Timmel/Timm/Vorwerk, Bergen /ID# 33451
Bergen, 18528
Wirtler, Bergisch Gladbach, DE /ID# 33452
Bergisch Gladbach, 51465
Charité Universitätsmedizin Campus Mitte /ID# 33457
Berlin, 10117
Hasert & Hasert, Berlin, DE /ID# 35531
Berlin, 10117
Kindler, Berlin, Germany /ID# 60604
Berlin, 10117
Klusmann, Berlin, DE /ID# 90974
Berlin, 10117
Spickermann, Berlin, DE /ID# 33675
Berlin, 10247
Praxis Dermatologie am Savigny /ID# 145783
Berlin, 10623
Herzler & Reupke, Berlin, DE /ID# 33705
Berlin, 10627
Boodstein, Berlin, Germany /ID# 48417
Berlin, 10783
Rothhaar, Berlin, DE /ID# 33644
Berlin, 10783
Simon, Berlin, DE /ID# 33678
Berlin, 10827
Steinhoff-Georgieva, Berlin,DE /ID# 60612
Berlin, 10827
Struss, Berlin, DE /ID# 33680
Berlin, 10967
Miller/Nerenheim, Berlin, DE /ID# 99842
Berlin, 12157
Praxis Dr. med. Meljanac /ID# 151477
Berlin, 12159
Praxis Dr. med. Meljanac /ID# 35594
Berlin, 12159
Jacob, Berlin, DE /ID# 48438
Berlin, 12163
Vivantes Klinikum Neukolln /ID# 34270
Berlin, 12351
Weihe/Stavermann, Berlin, DE /ID# 35547
Berlin, 12353
Gellrich, Berlin, DE /ID# 33691
Berlin, 12437
Schirmer, Berlin, DE /ID# 35534
Berlin, 12489
Skarabis/Skarabis, Berlin, DE /ID# 34241
Berlin, 12587
Kv Be /Id# 34253
Berlin, 12689
Praxis Dres. Eicholtz/Boerner /ID# 167676
Berlin, 13051
Wildfeuer, Berlin, DE /ID# 33694
Berlin, 13055
Kors, Berlin, DE /ID# 33649
Berlin, 13086
Zahn, Berlin, DE /ID# 35592
Berlin, 13187
Praxis Dr. Uhl /ID# 171308
Berlin, 13439
Dues/Manasterski, Berlin, DE /ID# 35538
Berlin, 13507
Miehe & Partner, Berlin, DE /ID# 166125
Berlin, 13507
Miehe & Partner, Berlin, DE /ID# 35544
Berlin, 13507
Baumann, Berlin, DE /ID# 60584
Berlin, 13593
Groene, Berlin, DE /ID# 60594
Berlin, 14052
Neumann, Bernau, DE /ID# 34271
Bernau, 16321
Praxis Dr. Duhn /ID# 167672
Bernau bei Berlin, 16321
Biel, Bielefeld, DE /ID# 60586
Bielefeld, 33602
MVZ Otto-Brenner-Straße /ID# 167677
Bielefeld, 33607
Staedt Kliniken Bielefeld /ID# 35558
Bielefeld, 33647
Dabour & Dabour, Birkenwerder /ID# 34280
Birkenwerder, 16547
Wege & Kuehnast, Bitterfeld /ID# 34282
Bitterfeld-Wolfen, 6749
Praxis fuer Innere Medizin/Rhe /ID# 35564
Blaubeuren Abbey, 89143
Ruppert, Bocholt, DE /ID# 108918
Bocholt, 46397
Klinikum Ruhr Univ Bochum /ID# 35091
Bochum, 44791
GP Dr. Niesman & Dr. Othlingha /ID# 169694
Bochum, 44793
Ardabili/Niesmann, Bochum, DE /ID# 50784
Bochum, 44803
Universitaetsklinikum Bonn /ID# 34299
Bonn, 53113
Praxis Dr. Schift /ID# 141549
Borken, 46325
Barth, Borna, DE /ID# 35650
Borna, 04552
Barth, Borna, DE /ID# 67946
Borna, 04552
Alte Apotheke /ID# 48530
Bottrop, 46236
Flont-Schmeling, Bottrop, DE /ID# 48423
Bottrop, 46236
Karpinski, Bottrop, DE /ID# 34303
Bottrop, 46236
Tolzin, Brake, DE /ID# 50866
Brake, 26919
Klee/Wolff, Brandenburg, DE /ID# 67960
Brandenburg, 14776
Praxis S. Osadtschy /ID# 161167
Brandenburg an der Havel, 14770
Atugoda, Braunschweig, DE /ID# 48509
Braunschweig, 38100
Gaedt, Braunschweig, DE /ID# 67954
Braunschweig, 38100
Koehn & Ramaker-Brunke, DE /ID# 34309
Braunschweig, 38114
Klinikverbund Bremen /ID# 171306
Bremen, 28205
Elsner, Bremen, DE /ID# 48422
Bremen, 28209
Derma am Diako /ID# 166131
Bremen, 28239
Hermann/Teichelmann, Bremen,DE /ID# 35605
Bremen, 28239
Altvater/Tauschke, Bremen, DE /ID# 34311
Bremen, 28259
Schwichtenberg, Bremen, DE /ID# 34312
Bremen, 28779
Friedmann, Bremerhaven, DE /ID# 67952
Bremerhaven, 27570
Heitmann, Bremerhaven, DE /ID# 148410
Bremerhaven, 27572
Bessle, Buchholz, DE /ID# 60585
Buchholz, 21244
Streit, Buchholz, DE /ID# 53723
Buchholz I.D. Nordheide, 21244
Arensmeier-Gottschalkson, Burg /ID# 48508
Burg, 39288
Praxis K. Neubert /ID# 149400
Burgstädt, 09217
Wagenpfeil, Burscheid, DE /ID# 99856
Burscheid, 51399
Elbe Klinikum Buxtehude /ID# 34694
Buxtehude, 21614
Praxis B. Jaeckel /ID# 145768
Chemnitz, 09116
Jaeckel & Partner, Chemnitz, D /ID# 34703
Chemnitz, 09119
Kuehn/Stengel, Chemnitz, DE /ID# 90978
Chemnitz, 09123
Praxis P. Hausler-Mehlhorn /ID# 149285
Chemnitz, 09130
Schneider, Chemnitz, DE /ID# 35613
Chemnitz, 9116
Hoffmann, Coburg, DE /ID# 34704
Coburg, 96450
Pappai, Coesfeld, DE /ID# 108917
Coesfeld, 48653
Uniklinik Koln /ID# 166128
Cologne, North Rhine-Westphalia, 50937
Karger/Rezazadegan, Cologne DE /ID# 60608
Cologne, 50679
Menge & Franckson, Cologne, DE /ID# 53708
Cologne, 50733
Haitas-Haase, Cologne, DE /ID# 53696
Cologne, 50935
Haase & Partner, Cologne, DE /ID# 53724
Cologne, 50969
Praxis Dres. Neuhaus/Sacha /ID# 149403
Cologne, 51103
Matias-Bako/Krickeberg,Cologne /ID# 90975
Cologne, 51109
Eichhorn, Cologne, DE /ID# 99818
Cologne, 51143
Krebs, Coswig, DE /ID# 48519
Coswig, 01640
Praxis S.-K. Strenzke /ID# 145781
Cottbus, 03046
Dr. Bernd Jantsch, Cottbus, DE /ID# 35618
Cottbus, 3046
Loessner, Cottbus, DE /ID# 34712
Cottbus, 3046
Dr. Susanne Jantsch,Cottbus,DE /ID# 35619
Cottbus, 3048
Klinikum Darmstadt GmbH /ID# 34720
Darmstadt, 64297
Buelow, Delmenhorst, DE /ID# 35626
Delmenhorst, 27749
Thelen, Delmenhorst, DE /ID# 35628
Delmenhorst, 27753
Heidlas, Dessau-Rosslau, DE /ID# 34730
Dessau, 6842
Klinikum Lippe Detmold GmbH /ID# 34731
Detmold, 32756
Friedrich, Dieburg, DE /ID# 53693
Dieburg, 64807
Gerharz, Diez, DE /ID# 48432
Diez, 65582
Winter, Dinkelsbuehl, DE /ID# 34734
Dinkelsbühl, 91550
Ghassem-Zadeh/Farashahi /ID# 138188
Dormagen, 41539
Thomas, Dorsten, DE /ID# 34736
Dorsten, 46282
Brinkmeier & Partner, Dortmund /ID# 138259
Dortmund, 44137
Brinkmeier & Partner, Dortmund /ID# 99847
Dortmund, 44137
Hautklinik Dortmund /ID# 72019
Dortmund, 44137
Hirschmueller, Dortmund, DE /ID# 34737
Dortmund, 44287
Bebnowski, Dortmund, DE /ID# 53684
Dortmund, 44309
Dick/Hubert/Mirkin, Dortmund /ID# 99843
Dortmund, 44369
Frolova, Dortmund, DE /ID# 51022
Dortmund, 44388
Praxis Dr. Büchner /ID# 204352
Dresden, Saxony, 01307
Frach/Hohaus, Dresden, DE /ID# 35166
Dresden, 01067
Frach/Hohaus, Dresden, DE /ID# 60600
Dresden, 01067
Gerlach, Dresden, DE /ID# 48433
Dresden, 01097
Praxis Dres. Pollack Schramm /ID# 149286
Dresden, 01097
Kuehn, Dresden, DE /ID# 34752
Dresden, 01109
Schamfuss, Dresden, DE /ID# 48468
Dresden, 01159
Richter-Huhn, Dresden, DE /ID# 35164
Dresden, 01219
Hass, Dresden, Germany /ID# 60597
Dresden, 01279
Meier, Dresden, DE /ID# 48452
Dresden, 01307
Universitaetklinikum Dresden /ID# 34764
Dresden, 01307
University Clinic Carl Gustav /ID# 99820
Dresden, 01307
Praxis Dr. Mayer /ID# 148243
Dresden, 01309
Scheibner, Dresden, DE /ID# 35162
Dresden, 1217
Oppers, Dresden, DE /ID# 126021
Dresden, 1277
Siebert, Duisburg, DE /ID# 34775
Duisburg, 47166
St. Barbara-Hospital /ID# 81302
Duisburg, 47167
Praxis. Y. Teoman /ID# 142005
Duisburg, 47179
Elsner, Duisburg, DE /ID# 99819
Duisburg, 47239
Saget & Riesopp, Duisburg, DE /ID# 35175
Duisburg, 47249
Praxis Dr. Lobert /ID# 145774
Duisburg, 47259
Bockhorst & Dominicus, Duelmen /ID# 34765
Dülmen, 48249
Korge, Dueren, DE /ID# 35174
Düren, 52349
Evangelisches Krankenhaus Dues /ID# 48419
Düsseldorf, 40217
Berendt, Eberswalde, DE /ID# 35178
Eberswalde, 16225
Badura, Eilenburg, DE /ID# 35179
Eilenburg, 4838
Praxis Dr. Kues /ID# 145771
Einbeck, 37574
Dove, Eisenach, DE /ID# 48420
Eisenach, 99817
Reinhardt, Eisenach, DE /ID# 48465
Eisenach, 99817
Rast, Eisenhuettenstadt, DE /ID# 34789
Eisenhüttenstadt, 15890
Richter/Cyw, Eisenhuettenstadt /ID# 34790
Eisenhüttenstadt, 15890
Noack, Lutherstadt Eisleben,DE /ID# 48521
Eisleben Lutherstadt, 06295
Schmid, Ellwangen, DE /ID# 34792
Ellwangen, 73479
Praxis Dr. Fitz /ID# 145767
Elmshorn, 25337
Hartl, Eltville, DE /ID# 34796
Eltville, 65343
Med X Aerzteteam GmbH /ID# 90977
Emden, 26721
Meinert, Emden, DE /ID# 34797
Emden, 26721
Maurer & Krebs-Posingies /ID# 34800
Emsdetten, 48282
Schurhammer-Fuhrmann, Endingen /ID# 67966
Endingen, 79346
Koenig, Erfurg, DE /ID# 99838
Erfurt, 99084
Nennstiel, Erfurt, DE /ID# 34804
Erfurt, 99091
Universitaetsklinikum Erlangen /ID# 34816
Erlangen, Bavaria, 91054
Lichtenstein, Eschweiler, DE /ID# 50842
Eschweiler, 52249
Praxis Dres. Exner/Kanja /ID# 145769
Essen, 45147
Universitaetsklinikum Essen /ID# 34827
Essen, 45147
Universitaetsklinikum Essen /ID# 53718
Essen, 45147
Klundt, Essen, DE /ID# 138195
Essen, 45327
Praxis Dres. Beyer /ID# 141989
Essen, 45329
Praxis Dres. Beyer /ID# 90957
Essen, 45329
Praxis Dr. Porwollik /ID# 148244
Essen, 45355
Praxis Dres. Renner/Sohl /ID# 149289
Esslingen am Neckar, 73728
Huerkamp, Euskirchen, DE /ID# 48517
Euskirchen, 53879
Swirski, Euskirchen, DE /ID# 81314
Euskirchen, 53879
Praxis Dres. Freitag/Knoell /ID# 167675
Falkensee, 14612
Jovic-Paris, Bad Neuenahr /ID# 48439
Fitzroy, 3065
Godt, Flensburg, DE /ID# 67957
Flensburg, 24939
Praxis T. Zimmermann /ID# 145784
Flöha, 09557
Eichinger, Frankenberg, DE /ID# 138260
Frankenberg, 09669
Schoengen/Schwarzenbach, Frank /ID# 60610
Frankenthal, 67227
Schoengen/Schwarzenbach, Frank /ID# 60611
Frankenthal, 67227
Kaufmann, Frankfurt, DE /ID# 35098
Frankfurt, 60596
Universitätsklinikum Frankfurt /ID# 53725
Frankfurt am Main, Hesse, 60590
Hundgeburth, Frechen, DE /ID# 138192
Frechen, 50226
Kaemmerer, Freiberg, DE /ID# 138194
Freiberg, 09599
Trefzer, Freiburg im Breisgau, /ID# 126028
Freiburg im Breisgau, 79098
Kurzen, Freising, DE /ID# 67964
Freising, 85354
Schmidt, Fuerstenwalde, DE /ID# 34868
Fürstenwalde, 15517
Gall, Fuerth, DE /ID# 48431
Fürth, 90762
Teichler, Gaggenau, DE /ID# 99855
Gaggenau, 76571
Wolf, Garbsen, DE /ID# 99859
Garbsen, 30823
Praxis Dr. Billmann-Krutmann /ID# 149399
Geilenkirchen, 52511
Praxis Dres. Kobus / Wetz /ID# 169692
Gelsenkirchen, 45886
Praxis K. R. Koerber & Partner /ID# 151715
Gelsenkirchen, 45894
Wetz, Gelsenkirchen, DE /ID# 99858
Gelsenkirchen, 45894
Rotterdam, Gelsenkirchen, DE /ID# 50856
Gelsenkirchen, 45897
Praxis J. Teichmann & Partner /ID# 145775
Gelsenkirchen, 45899
Lange, Dietrich & Beyer, Gera /ID# 48449
Gera, 07545
Lange, Dietrich & Beyer, Gera /ID# 81274
Gera, 07545
Paul/Meyer, Gera, DE /ID# 54379
Gera, 07545
SRH Wald-Klinikum Gera GmbH /ID# 60602
Gera, 07548
Schnee, Gera, DE /ID# 81313
Gera, 07549
Estel, Gera, DE /ID# 35226
Gera, 7546
Loth, Gernsbach, DE /ID# 50844
Gernsbach, 76593
Gross/Braeu, Giessen, DE /ID# 34884
Giessen, 35390
Kloevekorn & Tepe, Gilching /ID# 118541
Gilching, 82205
Kloevekorn & Tepe, Gilching /ID# 48504
Gilching, 82205
Kloevekorn & Tepe, Gilching /ID# 48506
Gilching, 82205
Brinkmann & Partner, Gladbeck, /ID# 34889
Gladbeck, 45964
Brinkmann & Partner, Gladbeck, /ID# 53688
Gladbeck, 45964
Jahn, Glauchau, DE /ID# 35230
Glauchau, 8371
Hille, Goerlitz, DE /ID# 60598
Görlitz, 02826
Cleffmann/Ranke, Goettingen DE /ID# 53689
Göttingen, 37073
Univ Medical Center Goettingen /ID# 35103
Göttingen, 37075
Kisslinger/Kisslinger, Grafena /ID# 34897
Grafenau, 94481
Kuckert, Graefenhainichen, DE /ID# 48520
Gräfenhainichen, 06773
Herrmann, Greifswald, DE /ID# 72016
Greifswald, 17489
Manke, Grevesmuehlen, DE /ID# 34907
Grevesmühlen, 23936
Wigbels, Gronau, DE /ID# 48505
Gronau, 48599
Grossmann, Grossenhain, DE /ID# 126016
Großenhain, 01558
Westphal, Guestrow, DE /ID# 35500
Güstrow, 18273
Busse-Misic, Hagen, DE /ID# 34914
Hagen, 58095
Timtschenko, Hagen, DE /ID# 138203
Hagen, 58095
Stehl, Haiger, DE /ID# 126027
Haiger, 35708
Gstoettner, Halle, DE /ID# 48513
Halle, 01632
Hamm, Halle, DE /ID# 72015
Halle, 06108
Lutze, Halle, DE /ID# 34919
Halle, 06108
Reiss, Halle, DE /ID# 35507
Halle, 06108
Zarzour, Halle, DE /ID# 35505
Halle, 06108
Hetschko, Halle, DE /ID# 48437
Halle, 06114
Universitatsklinikum Halle /ID# 34941
Halle, 6120
Gagu-Koll, Hamburg, DE /ID# 48424
Hamburg, 20148
Univ Klinik Eppendorf Hamburg /ID# 35115
Hamburg, 20246
Univ Klinik Eppendorf Hamburg /ID# 48453
Hamburg, 20246
Dermatologikum Hamburg /ID# 35107
Hamburg, 20354
Wagner, Hamburg, DE /ID# 99857
Hamburg, 20354
Mengert/Nienstedt, Hamburg, DE /ID# 34995
Hamburg, 21073
Luetten, Hamburg, DE /ID# 50847
Hamburg, 21109
Kahle/Ohnemus, Hamburg, DE /ID# 148412
Hamburg, 22041
Praxis Dres. Harms/Hartmann /ID# 148249
Hamburg, 22049
Buerger, Hamburg, DE /ID# 34966
Hamburg, 22111
Montag, Hamburg, DE /ID# 35438
Hamburg, 22143
Buck, Hamburg, DE /ID# 34964
Hamburg, 22305
Dermatologisches Ambulatorium /ID# 35435
Hamburg, 22391
Dermatologisches Ambulatorium /ID# 35436
Hamburg, 22391
Kunze, Hamburg, DE /ID# 34949
Hamburg, 22457
Kuwert/Wendt/Schulz, Hamburg, /ID# 34991
Hamburg, 22457
Hautarztpraxis am Tibarg /ID# 35004
Hamburg, 22459
Schmolke, Hamburg, DE /ID# 67965
Hamburg, 22523
Wrage-Brors, Hamburg, DE /ID# 126030
Hamburg, 22587
Szabo, Hamm, DE /ID# 35015
Hamm, 59065
Weitzel, Hamm, DE /ID# 90982
Hamm, 59065
Klinikum Hanau gGmbH /ID# 35020
Hanau, 63450
Praxis U. Stein /ID# 171307
Hanover, 30159
Theuerkauf, Hanover, DE /ID# 35454
Hanover, 30159
Stein, Hanover, DE /ID# 35029
Hanover, 30167
Horstmann, Hanover, DE /ID# 35026
Hanover, 30625
Universitaetsklinik Heidelberg /ID# 33810
Heidelberg, Baden-Wurttemberg, 69120
Universitaetsklinik Heidelberg /ID# 50858
Heidelberg, Baden-Wurttemberg, 69120
Durani & Durani, Heidelberg,DE /ID# 48421
Heidelberg, 69115
Alheit, Heidenau, DE /ID# 50782
Heidenau, 01809
Pawlak, Heilbad Heiligenstadt, /ID# 138191
Heilbad Heiligenstadt, 37308
Pawlak, Heilbad Heiligenstadt, /ID# 35466
Heilbad Heiligenstadt, 37308
Arnold/Kaschubowski/Salzer/Wur /ID# 67971
Heilbronn, 74072
Arnold/Kaschubowski/Salzer/Wur /ID# 99837
Heilbronn, 74072
Schulte/Mainusch, Heiligenhaus /ID# 138202
Heiligenhaus, 42579
Postrach, Hennigsdorf, DE /ID# 35468
Hennigsdorf, 16761
Praxis G. Taesler /ID# 145782
Herrnhut, 02747
Allmacher, Hersbruck, DE /ID# 125998
Hersbruck, 91217
PsoriSol Hautklinik GmbH /ID# 169690
Hersbruck, 91217
Kroemer, Herten, DE /ID# 48448
Herten, 45699
Badacz, Heusenstamm, DE /ID# 125999
Heusenstamm, 63150
Biedenkapp, Heusenstamm, DE /ID# 81275
Heusenstamm, 63150
Stark & Stark, Hilden, DE /ID# 35470
Hilden, 40721
About this study
Official title: Long Term Documentation of the Safety and Efficacy as Well as the Effects on Work Productivity in Patients With Moderate to Severe Plaque Psoriasis Treated With HUMIRA (Adalimumab) in Routine Clinical Practice (LOTOS)
Safety and Effectiveness of adalimumab (Humira) in Psoriasis Patients in Routine Clinical Practice.
Read the detailed description
Postmarketing Observational Study to Evaluate the Work Productivity, Safety and Efficacy of Humira for the Treatment of Moderate to Severe Plaque Psoriasis in Daily Clinical Practice. The primary objectives of the PMOS are to explore changes in health related care utilization data by the evaluation of:
- the number of missed working days
- the number of visits to doctor's office
- the number and duration of hospitalizations
- work ability to assess efficacy for different subgroups by
- the number of patients achieving a PASI 75 response to evaluate safety by
- the documentation and analysis of adverse events for all patients and subgroups with concomitant diseases Secondary objectives include the exploration of changes in quality of life measurements, of the influence of age, gender and duration of disease
- Conditions
- Moderate to Severe Plaque Psoriasis
- Keywords
- Moderate to Severe Plaque Psoriasis, Humira, Safety, Efficacy, Work Productivity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Psoriasis Patients | Patients with moderate to severe plaque psoriasis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in Psoriasis Area and Severity Index; number of patients with Psoriasis Area and Severity Index-75 reduction.
Measured: At 24, 48 and 60 months
Changes in healthcare parameters: number of missed working days due to psoriasis; number of visits at the doctor's office; number and duration of hospitalizations, self-assessed workability.
Measured: At 24, 48 and 60 months
Safety and tolerability assessed by analyzing serious and non-serous adverse events.
Measured: At 24, 48 and 60 months
Secondary outcomes (7)
Global physician's assessment on Humira treatment.
Measured: At 24, 48 and 60 months
Target Nail Psoriasis Severity Index (target NAPSI).
Measured: At 24 months
Itch Visual Analogue Scale (Itch VAS).
Measured: At 24 months
Safety and tolerability of Humira - treatment for patient groups with frequent concommitant diseases, especially diabetes type I and II, cardio-vascular and liver and kidney functional impairment and respective concommitant medication.
Measured: At 24, 48 and 60 months
Palmoplantar Psoriasis Area Severity Index (pPASI).
Measured: At 24 months
Influence of body mass index and weight on efficacy measurement.
Measured: At 24, 48 and 60 months
Patients' assessment on Humira treatment.
Measured: At 24, 48 and 60 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Mar 2010 (estimated)
- Study start4 Jan 2008
- Primary completion30 Jun 2019
- Study completion30 Jun 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Moderate to Severe Plaque PsoriasisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 5,442 participants (actual)
Sponsor and investigators
- Lead sponsor
- AbbVie (prior sponsor, Abbott)
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- AbbVie Inc., Study director, AbbVie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01077232
- Sponsor's protocol ID
- P10-446
- Acronym
- LOTOS
- Status last verified
- Jun 2020
- First submitted
- 25 Feb 2010
- Last updated
- 12 Jun 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 12 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Long Term Documentation of the Safety and Efficacy as Well as the Effects on Work Productivity in Patients With Moderate to Severe Plaque Psoriasis Treated With HUMIRA (Adalimumab) in Routine Clinical Practice (LOTOS)
- ClinicalTrials.gov ID
- NCT01077232
- Acronym / sponsor ID
- LOTOS / P10-446
- Conditions
- Moderate to Severe Plaque Psoriasis
- Keywords
- Moderate to Severe Plaque Psoriasis, Humira, Safety, Efficacy, Work Productivity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 5,442 participants (actual)
- Lead sponsor
- AbbVie (prior sponsor, Abbott)Industry (pharma, biotech, devices)
- Study start
- 4 Jan 2008 (actual)
- Primary completion
- 30 Jun 2019 (actual)
- Study completion
- 30 Jun 2019 (actual)
- First posted
- 1 Mar 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Safety and Effectiveness of adalimumab (Humira) in Psoriasis Patients in Routine Clinical Practice.
Detailed description
Postmarketing Observational Study to Evaluate the Work Productivity, Safety and Efficacy of Humira for the Treatment of Moderate to Severe Plaque Psoriasis in Daily Clinical Practice. The primary objectives of the PMOS are to explore changes in health related care utilization data by the evaluation of:
- the number of missed working days
- the number of visits to doctor's office
- the number and duration of hospitalizations
- work ability to assess efficacy for different subgroups by
- the number of patients achieving a PASI 75 response to evaluate safety by
- the documentation and analysis of adverse events for all patients and subgroups with concomitant diseases Secondary objectives include the exploration of changes in quality of life measurements, of the influence of age, gender and duration of disease
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Psoriasis Patients | – | –Patients with moderate to severe plaque psoriasis |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Community Sample: Patients with Plaque Psoriasis
Key inclusion criteria (1 listed)
- Moderate to severe plaque psoriasis in adults with no response to other systemic therapy (e.g. cyclosporine, methotrexate or PUVA (photochemical therapy)) or patients with a contraindication or hypersensitivity to such a therapy
Key exclusion criteria (1 listed)
- Hypersensitivity against the drug or one of the other ingredients; active tuberculosis or other severe infections (e.g. sepsis and opportunistic infections); moderate to severe cardiac insufficiency
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Changes in Psoriasis Area and Severity Index; number of patients with Psoriasis Area and Severity Index-75 reduction.
Time frame: At 24, 48 and 60 months
Changes in healthcare parameters: number of missed working days due to psoriasis; number of visits at the doctor's office; number and duration of hospitalizations, self-assessed workability.
Time frame: At 24, 48 and 60 months
Safety and tolerability assessed by analyzing serious and non-serous adverse events.
Time frame: At 24, 48 and 60 months
7 secondary outcomes
Global physician's assessment on Humira treatment.
Time frame: At 24, 48 and 60 months
Target Nail Psoriasis Severity Index (target NAPSI).
Time frame: At 24 months
Itch Visual Analogue Scale (Itch VAS).
Time frame: At 24 months
Safety and tolerability of Humira - treatment for patient groups with frequent concommitant diseases, especially diabetes type I and II, cardio-vascular and liver and kidney functional impairment and respective concommitant medication.
Time frame: At 24, 48 and 60 months
Palmoplantar Psoriasis Area Severity Index (pPASI).
Time frame: At 24 months
Influence of body mass index and weight on efficacy measurement.
Time frame: At 24, 48 and 60 months
Patients' assessment on Humira treatment.
Time frame: At 24, 48 and 60 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jun 2020.
- clinical study report synopsisLink provided by the sponsor.
- Individual participant dataSharing planned: Undecided
Related trials for Moderate to Severe Plaque Psoriasis
Active, not recruitingPhase 2
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
RecruitingPhase 1/2
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Not yet recruitingPhase 3
A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis
Palmoplantar Psoriasis
RecruitingPhase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Psoriasis, Overweight or Obesity
Active, not recruitingPhase 3
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
AbbVie Inc. study director
AbbVie
641 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Moderate to Severe Plaque Psoriasis, run by AbbVie (prior sponsor, Abbott) at 641 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 641 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in Psoriasis Area and Severity Index; number of patients with Psoriasis Area and Severity Index-75 reduction. (time frame: At 24, 48 and 60 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2020.